ACADIA Pharmaceuticals Inc.
ACAD
$21.72
-$0.08-0.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 375.65M | 391.00M | 261.17M | 222.16M | 228.88M |
| Total Depreciation and Amortization | 11.80M | 11.76M | 14.05M | 13.67M | 13.31M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -198.28M | -203.17M | -104.74M | -93.40M | -92.47M |
| Change in Net Operating Assets | -65.68M | -89.76M | 28.46M | 45.47M | -756.00K |
| Cash from Operations | 123.49M | 109.84M | 198.95M | 187.91M | 148.96M |
| Capital Expenditure | -9.90M | -4.69M | -1.14M | -820.00K | -523.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 146.52M | 146.52M | 146.52M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.33M | -297.87M | -269.92M | -273.35M | -286.54M |
| Cash from Investing | -112.23M | -302.56M | -124.55M | -127.65M | -140.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.28M | 49.88M | 29.19M | 20.03M | 7.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.28M | 49.88M | 29.19M | 20.03M | 7.64M |
| Foreign Exchange rate Adjustments | 56.00K | 26.00K | -41.00K | -83.00K | -104.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.59M | -142.82M | 103.55M | 80.20M | 15.95M |